Skip to content
Taxonomy
Advancements in CMT1A and CMT1B Research Highlight CMTA’s Impact
Exciting news from a CMTA-STAR-funded research project has been published Read More
Gene Therapy for CMT1A, 1B, and X1: Progress in Nanoparticles
In a jointly-funded project between CMTA and the Muscular Dystrophy Read More
Progress Update: Timmerman’s CMT1A Organoid Project Shows Early Success
CMTA is excited to report significant progress in its strategic Read More
Breakthrough in CMT1A Research: Community Efforts Drive Success of Dental Stem Cell Model
With the incredible support of the CMT community, Esther Wolfs, Read More
CMTA Partners with Actio Bio on CMT2C Focus Group
The Charcot-Marie-Tooth Association (CMTA), in collaboration with Actio Biosciences (Actio Read More
CMT2F Natural History Study Nears Full Recruitment as Biomarker Analysis Begins
With CMTA support of $302,071, an international team of researchers Read More
CMTA’s CRISPR Research Initiative Advances for CMT1A and CMT1B
The Charcot-Marie-Tooth Association (CMTA) continues its mission to accelerate research Read More
Your Participation Matters: Join the CMT2S Research Study
CMT2S: A Potential New Treatment on the Horizon Charcot-Marie-Tooth Disease Read More
CMTA’s Strategic Investment Advances Research for CMT1A and CMT1B
The Charcot-Marie-Tooth Association (CMTA) continues its mission to accelerate research Read More
Exploring New Therapeutic Pathways for CMT1B: UPR Activation
Researchers at the Ospedale San Raffaele (OSR) Scientific Institute in Read More
